Karena Kosco

843 total citations
17 papers, 445 citations indexed

About

Karena Kosco is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Karena Kosco has authored 17 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Karena Kosco's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Karena Kosco is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Karena Kosco collaborates with scholars based in United States and United Kingdom. Karena Kosco's co-authors include Tim C. Huffaker, Ian R. Adams, Edward D. Salmon, Chad G. Pearson, Paul S. Maddox, Kerry Bloom, Mark G. Erlander, Razelle Kurzrock, Michael J. Wolyniak and Scott M. Lippman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Karena Kosco

17 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karena Kosco United States 8 283 194 138 99 86 17 445
Gourish Mondal United States 11 304 1.1× 85 0.4× 79 0.6× 25 0.3× 110 1.3× 15 459
Ilenia Agliarulo Italy 11 372 1.3× 104 0.5× 159 1.2× 38 0.4× 75 0.9× 12 476
Isabel Soria‐Bretones Canada 9 293 1.0× 57 0.3× 84 0.6× 66 0.7× 126 1.5× 10 378
Donghua Gu China 13 385 1.4× 52 0.3× 202 1.5× 95 1.0× 79 0.9× 23 518
Shuzhou Chu China 13 288 1.0× 45 0.2× 92 0.7× 53 0.5× 92 1.1× 19 403
Dong-Jun Lin China 11 277 1.0× 107 0.6× 76 0.6× 13 0.1× 87 1.0× 11 420
Pier‐Luc Clermont Canada 10 360 1.3× 33 0.2× 154 1.1× 169 1.7× 65 0.8× 15 477
Masahiko Nezu Japan 10 226 0.8× 62 0.3× 46 0.3× 35 0.4× 63 0.7× 19 342
Evan R. Delgado United States 12 266 0.9× 78 0.4× 80 0.6× 20 0.2× 56 0.7× 23 455

Countries citing papers authored by Karena Kosco

Since Specialization
Citations

This map shows the geographic impact of Karena Kosco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karena Kosco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karena Kosco more than expected).

Fields of papers citing papers by Karena Kosco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karena Kosco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karena Kosco. The network helps show where Karena Kosco may publish in the future.

Co-authorship network of co-authors of Karena Kosco

This figure shows the co-authorship network connecting the top 25 collaborators of Karena Kosco. A scholar is included among the top collaborators of Karena Kosco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karena Kosco. Karena Kosco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pang, Andy Wing Chun, Karena Kosco, Nikhil Sahajpal, et al.. (2023). Analytic Validation of Optical Genome Mapping in Hematological Malignancies. Biomedicines. 11(12). 3263–3263. 7 indexed citations
2.
Kosco, Karena, et al.. (2020). Abstract 4262: Analytical validation of TruSight Oncology 500, a comprehensive genomic profiling LDT for use in routine patient care. Cancer Research. 80(16_Supplement). 4262–4262. 2 indexed citations
3.
Kosco, Karena, Maya Ridinger, Penn Whitley, et al.. (2018). Abstract 1885: Selective Polo-like Kinase 1 (PLK1) inhibitor PCM-075 is highly active alone and shows synergy when combined with FLT3 inhibitors in models of acute myeloid leukemia (AML). Cancer Research. 78(13_Supplement). 1885–1885. 3 indexed citations
4.
Husain, Hatim, Vladislava O. Melnikova, Karena Kosco, et al.. (2017). Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clinical Cancer Research. 23(16). 4716–4723. 106 indexed citations
5.
Husain, Hatim, et al.. (2015). Detection of EGFR T790M Mutation in Urinary Circulating Tumor Dna From Metastatic Non-Small Cell Lung Cancer Patients. Annals of Oncology. 26. i10–i10. 5 indexed citations
6.
Husain, Hatim, Karena Kosco, Cecile Rose T. Vibat, et al.. (2015). Kinetic monitoring of EGFR T790M in urinary circulating tumor DNA to predict radiographic progression and response in patients with metastatic lung adenocarcinoma.. Journal of Clinical Oncology. 33(15_suppl). 8081–8081. 11 indexed citations
7.
Kosco, Karena, Jason C. Poole, Saege Hancock, et al.. (2015). Abstract 5238: Methodology for single copy detection and quantitative monitoring of clinically actionable circulating tumor DNA mutations in urine from cancer patients. Cancer Research. 75(15_Supplement). 5238–5238. 1 indexed citations
8.
Jankú, Filip, Cecile Rose T. Vibat, Karena Kosco, et al.. (2014). BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. Oncotarget. 5(11). 3607–3610. 51 indexed citations
9.
Abdel‐Wahab, Omar, Eli L. Diamond, Minal Patel, et al.. (2014). Detection of BRAF mutations in urine and plasma cell-free DNA: Application to the diagnosis and management of histiocytic disorder patients.. Journal of Clinical Oncology. 32(15_suppl). 11012–11012. 2 indexed citations
10.
Jankú, Filip, Cecile Rose T. Vibat, Gerald S. Falchook, et al.. (2014). Longitudinal monitoring of BRAF V600E mutation in urinary cell-free DNA of patients with metastatic cancers.. Journal of Clinical Oncology. 32(15_suppl). e22175–e22175. 2 indexed citations
11.
Poole, Jason C., Filip Jankú, Veronica R. Holley, et al.. (2013). Abstract B177: Non-invasive tumor mutation detection of cell-free urinary DNA using massively parallel deep DNA sequencing.. Molecular Cancer Therapeutics. 12(11_Supplement). B177–B177. 1 indexed citations
12.
Jankú, Filip, Gerald S. Falchook, Sarina A. Piha‐Paul, et al.. (2013). Abstract B175: Detection and monitoring of BRAF and KRAS mutations in cell-free urinary DNA of metastatic cancer patients by droplet digital PCR.. Molecular Cancer Therapeutics. 12(11_Supplement). B175–B175. 1 indexed citations
13.
Alexiadis, Vassilios, et al.. (2012). Abstract 3198: The CEE-Selector Assay: A tool for the identification of rare allele variants. Cancer Research. 72(8_Supplement). 3198–3198. 1 indexed citations
14.
Brew, Christine Taylor, Ida Aronchik, Karena Kosco, et al.. (2008). Indole‐3‐carbinol inhibits MDA‐MB‐231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity. International Journal of Cancer. 124(10). 2294–2302. 45 indexed citations
15.
Kosco, Karena, Fabio Cerignoli, Scott Williams, Robert T. Abraham, & Tomas Mustelin. (2007). SKAP55 modulates T cell antigen receptor-induced activation of the Ras–Erk–AP1 pathway by binding RasGRP1. Molecular Immunology. 45(2). 510–522. 21 indexed citations
16.
Wolyniak, Michael J., et al.. (2006). The Regulation of Microtubule Dynamics in Saccharomyces cerevisiae by Three Interacting Plus-End Tracking Proteins. Molecular Biology of the Cell. 17(6). 2789–2798. 60 indexed citations
17.
Kosco, Karena, Chad G. Pearson, Paul S. Maddox, et al.. (2001). Control of Microtubule Dynamics by Stu2p Is Essential for Spindle Orientation and Metaphase Chromosome Alignment in Yeast. Molecular Biology of the Cell. 12(9). 2870–2880. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026